A new anti-obesity drug which could soon be available in Australia has been heralded as a better weight stripper than others already on the market.
With Britain battling the worst weight problem in Europe and just one obesity drug on the market, there is an urgent need for new weapons in the battle of the bulge.
A prototype obesity drug called STO 609 does just that and Dr Mills thinks it could be modified to treat prostate cancer which affects 36, 000 men in Britain.
